Skip to main content

Table 4 Objective Response (n = 24)

From: A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix

  n CR (%) PR (%) SD (%) PD (%)
All stages 24 23 (95.8) 1 (4.2) 0 (0) 0 (0)
Stage IIa2 - IIb 21 20 (95.2) 1 (4.8) 0 (0) 0 (0)
Stage IIIb 3 3 (3/3) 0 (0) 0 (0) 0 (0)